Invention Grant
- Patent Title: Method of inducing an anti-HIV-1 immune response comprising administering a C5/TM-GP41 peptide dimer
-
Application No.: US14405302Application Date: 2013-06-06
-
Publication No.: US10335482B2Publication Date: 2019-07-02
- Inventor: Birger Sorensen , Mats Okvist , Arnt Ove Hovden , Maja Sommerfelt Gronvold , Lars Hoie , Anker Lundemose , Vidar Wendel Hansen
- Applicant: Bionor Immuno AS
- Applicant Address: NO Skien
- Assignee: BIONOR IMMUNO AS
- Current Assignee: BIONOR IMMUNO AS
- Current Assignee Address: NO Skien
- Agency: Womble Bond Dickinson (US) LLP
- International Application: PCT/EP2013/061750 WO 20130606
- International Announcement: WO2013/182660 WO 20131212
- Main IPC: A61K39/21
- IPC: A61K39/21 ; A61K45/06 ; A61K31/429 ; A61K31/454 ; A61K31/675 ; C07K14/16 ; A61K38/15 ; A61K39/42 ; C12N7/00 ; A61K39/12 ; A61K47/60 ; A61K39/00
Abstract:
The present invention relates to novel combinations of active agents and methods for the treatment of HIV infection and AIDS. In particular, the present invention relates to novel combinations of (1) therapeutic agents which can effect stabilization of a complex between domains in certain HIV proteins with (2) HIV-specific vaccine peptides.
Public/Granted literature
- US20150132255A1 HIV VACCINE Public/Granted day:2015-05-14
Information query
